Shingles Recovery and Postherpetic Neuralgia: Pain Treatment and Prevention

Evidence reviewed: 8 November 2026. Shingles (herpes zoster) is caused by reactivation of varicella-zoster virus (VZV), which remains in sensory nerves after chickenpox. While the typical blistering rash heals in about two to four weeks, some people develop persistent, sometimes debilitating nerve pain called postherpetic neuralgia (PHN). Recovery requires attention to pain control, sleep, daily function, skin healing and, where appropriate, prevention through recombinant zoster vaccine (Shingrix). This article focuses on recovery and long-term nerve pain; see our companion shingles symptoms, acute antiviral therapy and vaccination guide for the initial infection [1–3].

How does shingles damage nerves?

VZV can remain dormant in dorsal root or cranial sensory ganglia. When it reactivates, inflammation along the affected nerve and skin can produce burning, stabbing, tingling or electric-like pain before and during the rash. In some cases, altered signaling in the peripheral and central nervous systems continues after skin lesions heal. PHN is therefore neuropathic pain, not ongoing infection of the skin in most cases [1,4].

Not every patient has persistent nerve injury. Pain may subside quickly in one person and remain severe for months in another. Persistent pain does not prove continued viral replication or mean that prolonged antiviral courses will cure PHN.

What is postherpetic neuralgia?

Postherpetic neuralgia refers to pain that persists in the area affected by shingles after the acute illness, often operationally defined as pain continuing 90 days or more after rash onset. Definitions vary somewhat among studies. CDC estimates that PHN occurs in approximately 10–18% of people with shingles, with risk increasing markedly with age [1].

Symptoms can include burning, stabbing, aching or electric shocks, reduced or altered sensation and allodynia—pain caused by normally harmless contact such as clothing or a light touch. Severe PHN can disrupt sleep, reduce appetite, restrict activity and contribute to depressed mood. It may last months or, occasionally, years [1,4].

Who is at higher risk for persistent shingles pain?

  • Older age, especially in adults over 60 or 70.
  • Severe pain at the beginning of the shingles episode.
  • A large or severe blistering rash and marked sensory symptoms.
  • Some patients with weakened immune systems or additional health problems.
  • Shingles involving cranial nerves or the eye, which also raises distinct complication concerns.

These factors indicate higher risk but do not reliably predict who will experience chronic pain. Prompt antiviral treatment helps acute disease, but evidence does not support promising that antiviral medicines alone will prevent every case of PHN [1,2].

Typical shingles recovery timeline

Stage Expected course When to seek assessment
Before the rash Unilateral tingling, burning or pain may precede skin changes by days. New severe chest pain or neurological symptoms require assessment of other emergencies.
Active rash Grouped blisters appear, often on one side of the trunk or face; new lesions may form for several days. Facial/eye involvement, widespread rash or immunosuppression needs prompt evaluation.
Crusting Blisters dry and scab; this usually develops during the first one to two weeks. Fever, spreading redness, pus or worsening pain may indicate complications.
Healing Skin usually improves over two to four weeks. Persistent pain or loss of function deserves treatment rather than reassurance alone.
Postherpetic neuralgia Neuropathic pain may continue after skin healing, sometimes for months. Consider neuropathic pain therapy and referral if severe or treatment resistant.

First treat active shingles appropriately

For a new shingles episode, acyclovir, valacyclovir or famciclovir may be prescribed to reduce viral replication and acute severity. These are most effective when started within 72 hours, but selected patients—especially those with new lesions, eye disease, immunosuppression or complications—may still need therapy later [1,2].

Do not continue antivirals for months simply because PHN remains. Chronic neuropathic pain generally needs a different approach after the acute viral illness has resolved. Antiviral choice and dose require attention to kidney function, age, other medicines and immune status.

How is postherpetic neuralgia diagnosed?

PHN is usually diagnosed through a history of prior shingles in the same distribution and persistent neuropathic pain. Clinicians assess pain intensity, touch sensitivity, sleep, mood and the effect on daily life. A prior classic rash makes the diagnosis more straightforward, while pain without rash may require exclusion of other causes such as radiculopathy, diabetic neuropathy, spinal disease or trigeminal neuralgia.

New weakness, bowel or bladder problems, fever or progressive neurological deficits should not be assumed to be ordinary PHN. Such findings require appropriate investigation.

Which medicines treat postherpetic neuralgia?

The NICE neuropathic pain guideline CG173 recommends offering amitriptyline, duloxetine, gabapentin or pregabalin as initial neuropathic pain treatment, with selection based on the clinical context. Topical lidocaine may be useful for localized PHN in selected patients under local authorization and expert advice [4]. No drug works equally well for everyone.

Option Why it is used Safety concerns
Gabapentin Modulates alpha-2-delta calcium-channel subunits involved in neuropathic signaling. Sleepiness, dizziness, falls, renal dose adjustment, additive sedation with opioids or alcohol.
Pregabalin Acts on related alpha-2-delta targets and may reduce neuropathic pain and sleep disturbance. Edema, weight gain, dizziness, dependence/misuse potential and renal dose adjustment.
Amitriptyline or another selected TCA Modulates descending pain pathways through monoamine reuptake inhibition. Dry mouth, constipation, orthostatic hypotension, cardiac effects and anticholinergic burden.
Duloxetine SNRI with evidence for neuropathic pain in various conditions. Nausea, blood-pressure changes, interactions and withdrawal effects.
Topical lidocaine Local sodium-channel blockade over a circumscribed painful area. Apply to healed, intact skin as directed; avoid applying to open blisters.

Choice is individualized. A patient with kidney impairment may require lower gabapentin or pregabalin doses, whereas an older adult with glaucoma, urinary retention or significant cardiac disease may be poorly suited to an anticholinergic tricyclic antidepressant. Starting all medicines together is not a guideline-directed first step.

Why gabapentin and pregabalin need careful dosing

Both are sometimes called gabapentinoids, but their dose schedules and pharmacokinetics differ. Clinicians usually start with a tolerable dose and adjust gradually based on response, sedation and kidney function. Abrupt discontinuation after regular use may cause withdrawal symptoms; a planned taper may be required [4].

Combining gabapentinoids with opioids, alcohol or other sedatives can increase the risk of dangerous sedation and respiratory depression in vulnerable people. The goal is meaningful reduction in pain and improved function, not simply a higher numerical dose.

What about topical lidocaine and capsaicin?

Lidocaine 5% patches are licensed for PHN in some jurisdictions and can be particularly useful when a small area of healed skin is painful from clothing contact. Follow instructions about the number of patches, application duration and intact skin. Do not cover an open, infected or newly blistered shingles rash with lidocaine patches without medical advice [4].

Capsaicin targets TRPV1 sensory pathways. A high-concentration capsaicin patch is a specialist-administered option for selected peripheral neuropathic pain patients; it is not equivalent to household chili paste. It can cause substantial burning during application and requires trained use. Over-the-counter low-concentration products have different evidence and tolerability.

Are opioids or corticosteroids useful for long-term pain?

Routine long-term opioids are generally discouraged for PHN because dependence, falls, sedation and overdose risks often outweigh uncertain sustained benefit. NICE advises against initiating certain opioids for neuropathic pain in nonspecialist settings, except limited acute rescue circumstances [4].

Systemic corticosteroids do not reliably prevent PHN and are not standard treatment for established chronic nerve pain. Any use during acute shingles must consider the reason, immune status, diabetes and infection risk. Antibiotics do not treat VZV or PHN unless a separate bacterial infection occurs.

Non-drug strategies and rehabilitation

Severe PHN affects sleep, movement, clothing tolerance and confidence. Care may include a comfortable dressing, graded movement, paced activity, support with sleep and mental health, and sometimes pain rehabilitation or psychological therapy for coping with persistent symptoms. These interventions do not imply the pain is imagined; neuropathic pain is a real nervous-system condition.

Patients can record pain patterns, medicine adverse effects and achievable functional goals such as sleeping longer, tolerating clothing or returning to gentle daily activity. When treatment causes substantial side effects without useful improvement, reassessment or switching options may be appropriate.

When to refer to a pain or neurology specialist

Referral is reasonable if pain remains severe, disabling or poorly responsive to appropriate first-line therapy, or if symptoms suggest another neurological condition. Some patients may benefit from specialist topical treatments, nerve blocks or other approaches, but effectiveness varies and these are not universally necessary [4].

Urgent assessment is different from routine pain referral: vision changes, facial weakness, severe headache, confusion, a new widespread rash or pronounced immunosuppression need prompt emergency or specialist care.

Can someone work or exercise during recovery?

Patients should balance rest, gentle activity and avoidance of unnecessary contact with active blisters. Whether to return to a workplace depends on symptoms, ability to keep lesions covered, job duties and exposure to vulnerable people. Healthcare workers and people caring for newborns or immunocompromised individuals may need specific infection-control or occupational advice [1].

Once the rash has healed, lingering PHN is generally not contagious. Pain may still reduce endurance and require reasonable workplace adjustments.

How long is shingles contagious?

Active shingles blisters contain VZV. Contact with the blister fluid can cause chickenpox in someone without varicella immunity; it does not directly cause shingles at the moment of exposure. Cover the rash, practice hand hygiene and avoid close contact with susceptible pregnant people, premature infants and immunocompromised individuals until all blisters have crusted [1].

Disseminated shingles and localized shingles in severely immunosuppressed patients may require enhanced healthcare isolation precautions. PHN after skin healing is not an infectious condition.

Does Shingrix prevent PHN?

Yes, by preventing shingles and its complications. CDC reports that Shingrix is more than 90% effective at preventing shingles and PHN in immunocompetent adults aged 50 years and older in studied populations [2,3]. Effectiveness can vary with age, immune status and time since vaccination.

The CDC recommends two Shingrix doses for adults aged 50 years and older and adults aged 19 years and older who are or will be immunodeficient or immunosuppressed because of disease or treatment. For most immunocompetent adults, doses are given two to six months apart; selected immunocompromised adults may receive the second dose one to two months after the first [2].

Vaccination remains indicated for eligible adults even if they previously had shingles, after the acute illness has resolved. Shingrix is not a treatment for active shingles or existing PHN and is not a substitute for the varicella (chickenpox) vaccine in someone who lacks varicella immunity.

How well tolerated is Shingrix?

Common reactions include arm pain, fatigue, headache, muscle aches, chills or fever during the first few days. These effects are usually temporary. Severe allergic reactions are rare and require urgent care. People receiving immune-modifying therapy may benefit from individualized vaccine timing [2,3].

Shingrix is non-live, unlike the discontinued live zoster vaccine. It is generally deferred in pregnancy under current CDC advice, and local national recommendations may differ.

What if someone has shingles more than once?

Recurrence can happen. New unilateral vesicular rash should be assessed as a fresh episode rather than assumed to be chronic PHN. The clinician may consider VZV PCR if the rash is atypical, and may review immune status when recurrences are frequent or severe. Eligible patients can still be vaccinated to reduce future risk [1,2].

Frequently asked questions

Does PHN mean I still have active shingles?

Usually no. PHN is persistent neuropathic pain after shingles rather than continuing active blister infection.

Can PHN last for years?

Yes. It may resolve gradually, but some people experience persistent symptoms for months or longer [1].

Is gabapentin a simple painkiller like paracetamol?

No. It targets neuropathic signaling, requires individualized dosing and can cause sedation and dizziness [4].

Can lidocaine patches be placed over fresh shingles blisters?

No. They should be used on healed, intact skin as instructed.

Will Shingrix cure existing nerve pain?

No. It helps prevent shingles and related complications, not treat established PHN.

Should I receive Shingrix after already having shingles?

Yes, if eligible, after the acute episode has resolved [2].

Key takeaways

Shingles skin lesions usually heal within weeks, but neuropathic pain may continue. Persistent PHN should be evaluated and managed with appropriate neuropathic pain treatment, often including gabapentin, pregabalin, selected antidepressants or topical lidocaine. Two-dose Shingrix vaccination is the most important specific prevention option for eligible adults.

References

  1. Centers for Disease Control and Prevention. Clinical overview of shingles (herpes zoster). Updated 2024; accessed 8 Nov 2026.
  2. Centers for Disease Control and Prevention. Shingles vaccine recommendations. 2024.
  3. Centers for Disease Control and Prevention. Shingles vaccination. 19 Aug 2025.
  4. National Institute for Health and Care Excellence. Neuropathic pain in adults: pharmacological management in non-specialist settings (CG173). NICE.
  5. National Institute of Neurological Disorders and Stroke. Postherpetic neuralgia. NIH; accessed 8 Nov 2026.

Medical disclaimer: Educational information only. Neuropathic pain medications may cause serious adverse effects and require individual prescribing, particularly in older adults or people with kidney disease. New visual changes, facial weakness, confusion or spreading rash require urgent medical evaluation.

Medical & AI Disclaimer

The information provided on Sumathi Publications is for general educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional regarding any medical condition or treatment decision.

We strive to keep our content accurate and up to date; however, some content may be created or assisted using artificial intelligence (AI) and may contain errors or omissions. All information should be independently verified before use. Reliance on any content provided by Pharmacology Mentor is at your own risk.

Leave a Reply

Your email address will not be published. Required fields are marked *